Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. FDA to weigh easing limits on unproven peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Q&A: Should you trust trending peptide injections? BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn When will the FDA reclassify BPC 157 to Category 1 Octagon AI